Privia Health Group, Inc.(PRVA US)
$22.81+0.411.83%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 389.5 | 491.1 | 479.7 | 419.5 | |||||||
| Short Term Investments | - | - | - | - | |||||||
| Cash and Short Term Investments | 389.5 | 491.1 | 479.7 | 419.5 | |||||||
| Net Receivables | 290.8 | 316.2 | 400.9 | 513.7 | |||||||
| Inventory | - | - | - | - | |||||||
| Other Current Assets | 20.5 | 27.5 | 30.4 | 32.8 | |||||||
| Total Current Assets | 700.8 | 834.8 | 911.0 | 966.0 | |||||||
| Property, Plant & Equipment | 8.9 | 6.1 | 9.3 | 8.7 | |||||||
| Long Term Investments | - | - | - | - | |||||||
| Other Non-Current Assets | 8.6 | 17.1 | 21.0 | 20.6 | |||||||
| Total Non-Current Assets | 299.1 | 301.0 | 458.4 | 451.9 | |||||||
| Total Assets | 999.9 | 1,135.8 | 1,369.4 | 1,417.9 | |||||||
| Account Payables | 7.9 | 9.8 | 8.0 | 529.3 | |||||||
| Short Term Debt | - | - | - | - | |||||||
| Deferred Revenue | - | - | - | - | |||||||
| Other Current Liabilities | 332.1 | 370.6 | 503.1 | 14.3 | |||||||
| Total Current Liabilities | 387.0 | 449.1 | 568.5 | 601.3 | |||||||
| Long Term Debt | - | - | - | - | |||||||
| Other Non-Current Liabilities | 0.3 | 0.2 | 2.6 | 3.5 | |||||||
| Total Non-Current Liabilities | 5.6 | 3.2 | 9.9 | 10.7 | |||||||
| Total Liabilities | 392.5 | 452.3 | 578.4 | 612.0 | |||||||
| Common Stock | 1.2 | 1.2 | 1.2 | 1.3 | |||||||
| Retained Earnings | -193.6 | -179.2 | -156.3 | -153.2 | |||||||
| Total Stockholders Equity | 561.4 | 635.2 | 737.2 | 753.1 | |||||||
| Total Liabilities and Equity | 999.9 | 1,135.8 | 1,369.4 | 1,417.9 | |||||||
| Millions USD (ex. Per Share) | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | 389.5 | 491.1 | 479.7 | 419.5 | |||||||
| Short Term Investments | - | - | - | - | |||||||
| Cash and Short Term Investments | 389.5 | 491.1 | 479.7 | 419.5 | |||||||
| Net Receivables | 290.8 | 316.2 | 400.9 | 513.7 | |||||||
| Inventory | - | - | - | - | |||||||
| Other Current Assets | 20.5 | 27.5 | 30.4 | 32.8 | |||||||
| Total Current Assets | 700.8 | 834.8 | 911.0 | 966.0 | |||||||
| Property, Plant & Equipment | 8.9 | 6.1 | 9.3 | 8.7 | |||||||
| Long Term Investments | - | - | - | - | |||||||
| Other Non-Current Assets | 8.6 | 17.1 | 21.0 | 20.6 | |||||||
| Total Non-Current Assets | 299.1 | 301.0 | 458.4 | 451.9 | |||||||
| Total Assets | 999.9 | 1,135.8 | 1,369.4 | 1,417.9 | |||||||
| Account Payables | 7.9 | 9.8 | 8.0 | 529.3 | |||||||
| Short Term Debt | - | - | - | - | |||||||
| Deferred Revenue | - | - | - | - | |||||||
| Other Current Liabilities | 332.1 | 370.6 | 503.1 | 14.3 | |||||||
| Total Current Liabilities | 387.0 | 449.1 | 568.5 | 601.3 | |||||||
| Long Term Debt | - | - | - | - | |||||||
| Other Non-Current Liabilities | 0.3 | 0.2 | 2.6 | 3.5 | |||||||
| Total Non-Current Liabilities | 5.6 | 3.2 | 9.9 | 10.7 | |||||||
| Total Liabilities | 392.5 | 452.3 | 578.4 | 612.0 | |||||||
| Common Stock | 1.2 | 1.2 | 1.2 | 1.3 | |||||||
| Retained Earnings | -193.6 | -179.2 | -156.3 | -153.2 | |||||||
| Total Stockholders Equity | 561.4 | 635.2 | 737.2 | 753.1 | |||||||
| Total Liabilities and Equity | 999.9 | 1,135.8 | 1,369.4 | 1,417.9 | |||||||